Posted in

News And Events

Impulse Control Disorders Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial (P8-11.002)

Congratulations to Drs. Stiep, Rameriz-Zamora and Okun on the publication of “Impulse Control Disorders Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial (P8-11.002),” in the May issue of Neurology. Abstract Objective: To assess the frequency and outcomes of impulsivity in study participants receiving bilateral…

Apathy Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial (P8-11.001)

Congratulations to Drs. Stiep, Rameriz-Zamora and Okun on the publication of “Apathy Following Bilateral Subthalamic Deep Brain Stimulation for Parkinson’s Disease: The INTREPID Randomized Controlled Trial (P8-11.001),” in the May issue of Neurology. Abstract Objective: To determine frequency and predictors of both improvement and worsening of apathy in participants receiving…

Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual)

Congratulations to Dr Nikolaus Mc Farland for his recent publication, “Enhancing Pandemic-Sensitive Recruitment Strategies for a Remote, Randomized Placebo-Controlled Trial for Fracture Prevention in Patients with Neurodegenerative Parkinsonisms (P1-1.Virtual)”.  This article was published in the  May issue of Neurology.   Abstract Objective: To develop a diversified recruitment model for the…

Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy

Congratulations to Drs. McFarland, Okun and Vaillancourt on the publication of “Advanced diffusion imaging to track progression in Parkinson’s disease, multiple system atrophy, and progressive supranuclear palsy,” in the current issue of Neuroimage: Clinical.   Abstract Advanced diffusion imaging which accounts for complex tissue properties, such as crossing…

UF neuroscientists awarded grants to advance Lewy body dementia research

Lewy body dementia is the second-most common form of neurodegenerative dementia in the U.S. behind Alzheimer’s disease. To help combat this growing health issue, which affects over 1 million individuals in the U.S., the Harry T. Mangurian Jr. Foundation supports the Collaboration for Pilot Studies in Lewy Body Dementia, an…

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson’s Disease

Congratulations Drs. David Vaillancourt and Nikolaus McFarland on the publication of “Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson’s Disease, in the April edition of Movement Disorders. Abstract Background Differentiating progressive supranuclear palsy-parkinsonism (PSP-P) from Parkinson’s disease (PD) is clinically challenging.

UF neurologists featured in Clinical Neurology Update

University of Florida neurologists Michael Jaffee, M.D., and Yulia Orlova, M.D., are featured in the April 2022 edition of Clinical Neurology Update, from The New England Journal of Medicine (NEJM) Group. Jaffee, vice chair of UF neurology and director of UF’s Brain Injury, Rehabilitation, and Neuroresilience Center, served as editor of…

Congratulations Dr. Okun!

Congratulations to University of Florida College of Medicine physician-scientist Michael Okun, M.D., professor and chair of the department of neurology, on his…